Investment Summary

Eight Roads Invests In div

On May 29, 2020, private equity firm Eight Roads invested in education company div

Investment Highlights
  • This is Eight Roads’ 5th transaction in the Education sector.
  • This is Eight Roads’ 23rd transaction in Japan.

Investment Summary

Date 2020-05-29
Target div
Sector Education
Investor(s) Eight Roads
Deal Type Venture

Target

div

Tokyo, Japan
div operates “Tech Camp”, a programming school, a short-term intensive training course designed to turn students into engineers. div was founded in 2012 and is based in Tokyo, Japan.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 235 of 293
Sector: Education M&A 5 of 8
Type: Venture M&A Deals 212 of 266
Country: Japan M&A 23 of 25
Year: 2020 M&A 13 of 18
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-27 Otrium

Amsterdam, Netherlands

Otrium is a purpose-driven platform that envisions a world where all clothing that is produced is worn. With a technology-led approach, Otrium connects a growing global community with excess stock from leading brands. Otrium was founded in 2015 and is based in Amsterdam, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-11 Avidity Biosciences

San Diego, California, United States

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies using its proprietary antibody oligonucleotide conjugate platform. Avidity Biosciences was founded in 2012 and is based in San Diego, California.

Sell -